Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-FR Version v1-EN
Language French English
Date Updated 2017-04-04 2017-03-13
Drug Identification Number 02295318 02295318
Brand name APO-ATORVASTATIN APO-ATORVASTATIN
Common or Proper name ATORVASTATIN ATORVASTATIN
Company Name APOTEX INC APOTEX INC
Ingredients ATORVASTATIN ATORVASTATIN
Strength(s) 80MG 80MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 30 BLS 30 BLS
ATC code C10AA C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-03-10 2017-03-10
Estimated end date 2017-03-31 2017-03-31
Actual end date 2017-04-03
Shortage status Resolved Actual shortage
Company comments APO-ATORVASTATIN FCT 80MG 100 BTL IS AVAILABLE APO-ATORVASTATIN FCT 80MG 100 BTL IS AVAILABLE
Health Canada comments